AbCellera Biologics, Inc. (ABCL)

3.10 +0.16 (+5.44%) USD  |  NASDAQ  |  Feb 13, 16:00
3.19 +0.09 (+2.90%) Pre-Market: 20:00
More

AbCellera Biologics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ABCL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Achieve Life Sciences, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade